SRNE

PINK Sorrento Therapeutics, Inc.
Oct 8, 2026 · 6:13 AM ET EOD Market Closed

$0.0008 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0008, and at the day’s high of $0.0008

YTD change
-69.23%
vs 20-day SMA
+34.45%
vs 200-day SMA
-48.92%

Price ranges

Previous day
$0.0008 $0.0008
open $0.0008 close $0.0008
+$0.0000 (+0.00%)
Today
$0.0008 $0.0008
$0.0008
Past week
$0.0005 $0.0010
from $0.0008 now $0.0008
+$0.0000 (+0.00%)
Past month
$0.0001 $0.0010
from $0.0004 now $0.0008
+$0.0004 (+100.00%)
This year
$0.0001 $0.0100
from $0.0026 now $0.0008
-$0.0018 (-69.23%)

Price & Performance

-0.00 (-68.00%) / 6M

$0.0001$0.0010$0.0018$0.0027Apr 8Jul 9Oct 7

Signals & Sentiment

Momentum, market sentiment, and recent alerts

N/A
  • The stock is 99.2% away from all-time highs of $0.0985
  • SRNE is down 69% since the beginning of the year
  • SRNE is down 80% over the past 12 months
  • SRNE is up 100% over the past 1 month
  • 1% of all SRNE investors are betting against SRNE

SRNE reads n/a: price sits above one of the two key moving averages, the 12-month move is -82.2%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable N/A
EPS N/A
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Beta -4.27

Balance sheet & scale

IncomeN/A
RevenueN/A
CashN/A
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangePINK
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $441.0K

Sorrento Therapeutics, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It operates through the Sorrento Therapeutics and Scilex segments. The Sorrento Therapeutics segment consists of developing a portfolio of next generation treatments for three major therapeutic areas: cancer, infectious disease, and pain. The Scilex segment is largely organized around the company's non-opioid pain management operations. The company was founded by Henry H. Ji in 1989 and is headquartered in San Diego, CA.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,188.72 +2.70%
JNJ Johnson & Johnson $258.45 +1.44%
ABBV AbbVie, Inc. $271.36 +1.75%
MRK Merck & Co., Inc. $142.79 +0.60%
RHHBY Roche Holding Ltd Sponsored ADR $54.07 +2.89%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.